Whereas there is lack of concrete explanation, clinical manifestations of COVID-19 may depend on the distribution of the angiotensin converting enzyme 2 (ACE2) in the respiratory airway epithelium (Wu et al., 2021). The gene discussed is ACE2; the disease is COVID-19.